Clinical characteristics and evolution of 71 neonates born to mothers with COVID-19 at a tertiary center in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.77, article ID 100136, 5p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Limited data are available on pregnant women with COVID-19 and their neonates.Objective: This study aimed to describe clinical characteristics and evolution from birth to discharge of a retrospec-tive cohort of 71 neonates, with one set of twins, born to women with COVID-19 diagnosed at the end of preg-nancy. The authors included all newborns admitted into a neonatal unit of a tertiary hospital in Brazil, between March 2020 and March 2021, whose unvaccinated mothers had COVID-19 symptoms and RT-PCR (Real-Time Polymerase Chain Reaction) for SARS-CoV-2 positive within fourteen days prior to delivery. Newborns to mothers with COVID-19 symptoms and negative tests for SARS-CoV-2 were excluded. Results: The main route of birth delivery was cesarean, corresponding to 60 pregnant women (84.5%). The fore-most indications for cesarean were pregnant with critical disease (24.6%) and acute fetal distress (20.3%). The mean birth weight was 2452 g (865-3870 g) and the mean gestational age was 345/7 weeks (25-40 weeks). There were 45 premature newborns (63.3%), of which 21 newborns (29.5%) were less than 32 weeks of gestational age. RT-PCR for SARS-CoV-2 on oropharyngeal swabs was positive in 2 newborns (2.8%) and negative in the other 69 newborns (97.2%). Most newborns (51.4%) needed respiratory support. Therapeutic interventions dur-ing hospitalization were inotropic drugs (9.9%), antibiotics (22.8%), parenteral nutrition (26.8%), and photother-apy (46.5%).Conclusion: Maternal COVID-19 diagnosticated close to delivery has an impact on the first days of neonatal life.
Palavras-chave
Neonatology, COVID-19, Newborn, Brazil
Referências
  1. Angelidou A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.7523
  2. [Anonymous], 2020, WHO DIRECTOR GEN OPE
  3. Bellos I, 2021, EUR J OBSTET GYN R B, V256, P194, DOI 10.1016/j.ejogrb.2020.11.038
  4. Brazilian Pediatrics Society, 2012, FOLL UP AMB PREM RIS, P607
  5. Brazilian Pediatrics Society, 2021, REC HOSP DISCH POT H, P1
  6. Chi JH, 2021, ARCH GYNECOL OBSTET, V303, P337, DOI 10.1007/s00404-020-05889-5
  7. Cimolai Nevio, 2021, SN Compr Clin Med, V3, P1272, DOI 10.1007/s42399-021-00836-0
  8. Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
  9. dos Santos Beozzo Glenda Priscila Neves, 2020, Clinics, V75, pe2407, DOI 10.6061/clinics/2020/e2407
  10. Dumitriu D, 2021, JAMA PEDIATR, V175, P157, DOI 10.1001/jamapediatrics.2020.4298
  11. Farmer ML, 2021, ADV NEONAT CARE, V21, P482, DOI 10.1097/ANC.0000000000000954
  12. Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
  13. Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66
  14. Kimberlin DW, 2020, JAMA-J AM MED ASSOC, V323, P1788, DOI 10.1001/jama.2020.4868
  15. Lamouroux A, 2020, AM J OBSTET GYNECOL, V223, P91, DOI 10.1016/j.ajog.2020.04.039
  16. Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
  17. Martinelli KG, 2021, REV BRAS ESTUD POPUL, V38, P1
  18. Metz TD, 2021, OBSTET GYNECOL, V137, P571, DOI 10.1097/AOG.0000000000004339
  19. Norman M, 2021, JAMA-J AM MED ASSOC, V325, P2076, DOI 10.1001/jama.2021.5775
  20. Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5
  21. Papapanou M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020596
  22. Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133
  23. Reid A, 2005, MED HIST, V49, P29, DOI 10.1017/S0025727300008279
  24. Sanchez-Luna M, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-015065
  25. Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P1451, DOI 10.5858/arpa.2020-0442-SA
  26. Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
  27. Smith V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234187
  28. Trippella G, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9060485
  29. Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050
  30. Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6
  31. Wells JCK, 2019, LANCET, V394, P24, DOI 10.1016/S0140-6736(19)30715-9
  32. WHO, 2021, LIV GUID CLIN MAN CO, P63
  33. Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014
  34. Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
  35. Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]
  36. Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P469, DOI 10.1097/INF.0000000000002700